CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits to the stakeholders
1.3.Key market segments
1.4.Research Methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top winning strategies
3.2.2.Top investment pockets

3.3.Government Regulations

3.3.1.Center for Veterinary Biologics (CVB)

3.4.Top player positioning
3.5.Porter's five forces analysis
3.6.Market dynamics

3.6.1.Drivers

3.6.1.1.Growth in demand for pet insurance
3.6.1.2.Increase in prevalence of animal diseases
3.6.1.3.Growth in ownership of companion animal
3.6.1.4.Rise in animal health expenditure

3.6.2.Restraints

3.6.2.1.Highly competitive meat and milk prices
3.6.2.2.Adverse impact of veterinary vaccines on human and animal health

3.6.3.Opportunities

3.6.3.1.Advancement in vaccine products
3.6.3.2.Increase in demand for hybrid animal

CHAPTER 4:ANIMAL VACCINES MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Attenuated Vaccines

4.2.1.Key market trends, key growth factors and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Inactivated Vaccines

4.3.1.Key market trends, key growth factors and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Subunit Vaccines

4.4.1.Key market trends, key growth factors and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

4.5.Toxoid Vaccines

4.5.1.Key market trends, key growth factors and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country

4.6.Conjugate Vaccines

4.6.1.Key market trends, key growth factors and opportunities
4.6.2.Market size and forecast
4.6.3.Market analysis, by country

4.7.Recombinant Vaccines

4.7.1.Key market trends, key growth factors and opportunities
4.7.2.Market size and forecast
4.7.3.Market analysis, by country

4.8.DNA Vaccines

4.8.1.Key market trends, key growth factors and opportunities
4.8.2.Market size and forecast
4.8.3.Market analysis, by country

CHAPTER 5:ANIMAL VACCINES MARKET, BY ANIMAL TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Companion animal

5.2.1.Market size and forecast, by type

5.2.1.1.Dogs

5.2.1.1.1.Market size and forecast

5.2.1.2.Cats

5.2.1.2.1.Market size and forecast

5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Livestock Animal

5.3.1.1.Cattle

5.3.1.1.1.Market size and forecast

5.3.1.2.Pigs

5.3.1.2.1.Market size and forecast

5.3.1.3.Poultry

5.3.1.3.1.Market size and forecast

5.3.1.4.Sheep

5.3.1.4.1.Market size and forecast

5.3.1.5.Others

5.3.1.5.1.Market size and forecast

5.3.2.Market size and forecast
5.3.3.Market analysis, by country

5.4.Aquaculture

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

CHAPTER 6:ANIMAL VACCINES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends
6.2.2.Key growth factors and opportunities
6.2.3.Market size and forecast, by product
6.2.4.Market size and forecast, by animal type
6.2.5.Market size and forecast, by country

6.2.5.1.U.S. market size and forecast, by product
6.2.5.2.U.S. market size and forecast, by animal type
6.2.5.3.Canada market size and forecast, by product
6.2.5.4.Canada market size and forecast, by animal type
6.2.5.5.Mexico market size and forecast, by product
6.2.5.6.Mexico market size and forecast, by animal type

6.3.Europe

6.3.1.Key market trends
6.3.2.Key growth factors and opportunities
6.3.3.Market size and forecast, by product
6.3.4.Market size and forecast, by animal type
6.3.5.Market size and forecast, by country

6.3.5.1.Germany market size and forecast, by product
6.3.5.2.Germany market size and forecast, by animal type
6.3.5.3.France market size and forecast, by product
6.3.5.4.France market size and forecast, by animal type
6.3.5.5.UK market size and forecast, by product
6.3.5.6.UK market size and forecast, by animal type
6.3.5.7.Italy market size and forecast, by product
6.3.5.8.Italy market size and forecast, by animal type
6.3.5.9.Rest of Europe market size and forecast, by product
6.3.5.10.Rest of Europe market size and forecast, by animal type

6.4.Asia-Pacific

6.4.1.Key market trends
6.4.2.Key growth factors and opportunities
6.4.3.Market size and forecast, by product
6.4.4.Market size and forecast, by animal type
6.4.5.Market size and forecast, by country

6.4.5.1.Japan market size and forecast, by product
6.4.5.2.Japan market size and forecast, by animal type
6.4.5.3.China market size and forecast, by product
6.4.5.4.China market size and forecast, by animal type
6.4.5.5.Australia market size and forecast, by product
6.4.5.6.Australia market size and forecast, by animal type
6.4.5.7.India market size and forecast, by product
6.4.5.8.India market size and forecast, by animal type
6.4.5.9.South Korea market size and forecast, by product
6.4.5.10.South Korea market size and forecast, by animal type
6.4.5.11.Rest of Asia-Pacific market size and forecast, by product
6.4.5.12.Rest of Asia-Pacific market size and forecast, by animal type

6.5.LAMEA

6.5.1.Key market trends
6.5.2.Key growth factors and opportunities
6.5.3.Market size and forecast, by product
6.5.4.Market size and forecast, by animal type
6.5.5.Market size and forecast, by country

6.5.5.1.Brazil market size and forecast, by product
6.5.5.2.Brazil market size and forecast, by animal type
6.5.5.3.Saudi Arabia market size and forecast, by product
6.5.5.4.Saudi Arabia market size and forecast, by animal type
6.5.5.5.Rest of LAMEA market size and forecast, by product
6.5.5.6.Rest of LAMEA market size and forecast, by animal type

CHAPTER 7:COMPANY PROFILES

7.1.Anicon Labor GmbH

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio

7.2.Boehringer Ingelheim GmbH

7.2.1.Company overview
7.2.2.Operating business segments
7.2.3.Business performance

7.3.Ceva Sante Animale

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Product portfolio
7.3.4.Business performance
7.3.5.Key strategic moves & developments

7.4.Hygieia Biological Laboratories

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio

7.5.Merck & company Inc.

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments

7.6.Romvac company S.A.

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio

7.7.Sanofi S.A.

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments

7.8.Vaxxinova Gmbh-Germany

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Key strategic moves and developments

7.9.Virbac S.A

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance

7.10.Zoetis Inc.

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves & developments